
Cambridge-based Artios Pharma has officially launched after raising £25 million in series A financing from US and European life science …

The University of Sussex is set to produce a portfolio of new cancer drugs which exploit our DNA damage response …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

